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Introduction {#sec001}
============

TiO~2~ nanoparticles (TNPs) have been widely used in diverse areas. There have been more than 1,600 nanotechnology-based consumer products on the market \[[@pone.0122591.ref001]\]. Among them, about 197 products are based on TNPs. These products ranges from environmental remediation \[[@pone.0122591.ref002], [@pone.0122591.ref003]\], and cosmetics \[[@pone.0122591.ref004]\] to food additives \[[@pone.0122591.ref005]\], and nanomedicine \[[@pone.0122591.ref006]\], antibacterial materials \[[@pone.0122591.ref007], [@pone.0122591.ref008]\]. Applications of nanomaterials and nanotechnology have increased the environmental release and accumulation of nanoparticles and the human exposure to these materials \[[@pone.0122591.ref009], [@pone.0122591.ref010]\]. For example, TNPs released from exterior paint of urban buildings contaminate surface waters \[[@pone.0122591.ref010]\] and these nanoparticles cause toxicity in aquatic organisms \[[@pone.0122591.ref011]\].

Nano pollution to the environment and nanomedicine application of TNPs has raised concerns about the potential nanotoxic effects to humans, especially to vulnerable populations, such as lactating females. Breastfeeding, or lactation, is considered essential to growth \[[@pone.0122591.ref012]\], active and passive immunity \[[@pone.0122591.ref013]\], and cognitive and psychosocial development of newborns \[[@pone.0122591.ref014]\]. It has been recommended that exclusive breastfeeding should last for at least six months after a baby is born \[[@pone.0122591.ref013]\]. However, there have been indications that nanoparticles are present in rat milk via an unknown mechanism when lactating dams are exposed to nanoparticles \[[@pone.0122591.ref015], [@pone.0122591.ref016]\]. This finding indicates that nanoparticle exposure may pose dangers to both the mother and newborn during and after the lactation period.

Nanoparticles' exposures through inhalation, digestion, and skin contact eventually lead to their absorption into the blood and their distribution to various organs \[[@pone.0122591.ref017]\]. Organs exhibit different sensitivities to nanoparticle perturbations. Physiological barriers are used to protect vulnerable organs or processes. Among these protections, the blood-milk barrier provides important protection for milk integrity and the health of pups. Nanoparticles induce the breakdown of some important physiological barriers \[[@pone.0122591.ref018]--[@pone.0122591.ref020]\]. Silica nanoparticles and TNPs induce blood-placental barrier damage \[[@pone.0122591.ref018]\]. Multiwalled carbon nanotubes \[[@pone.0122591.ref019]\] and gold nanoparticles \[[@pone.0122591.ref020]\] cross the blood--testis barrier and cause damage to the testis. Although nanoparticles were found in milk after dam's exposure \[[@pone.0122591.ref015], [@pone.0122591.ref016]\], questions regarding whether and how nanoparticles compromise the blood-milk barrier remain unanswered.

In this investigation, we revealed the effects of TNPs on lactating dams and their pups during the lactation period after four intravenous (i.v.) administrations of TNPs of different sizes (8 nm and 50 nm). TNPs, especially the smaller ones, were observed to enter the mammary glands of dams, induce reactive oxygen species (ROS), and damage the integrity of the blood-milk barrier by causing shedding of alveolar epithelial cells and inducing gaps in the tight junction of the barrier. These effects allow the passage of TNPs into milk and subsequently to the pups' gastrointestinal (GI) tract. At the applied doses and under our experimental conditions, the milk quality and the pups' early developmental landmarks were not affected during the lactation period.

Materials and Methods {#sec002}
=====================

Our experimental protocols complied with the NIH guidelines outlined in the Guide for the Care and Use of Laboratory Animals and were approved by the Committee on the Ethics on Animal Experimentation of Shandong University.

TNP Characterization {#sec003}
--------------------

Anatase-type TiO~2~ nanoparticles were purchased from Shanghai Jingchun Co., Ltd. (Shanghai, China). The crystal structure of TNP-8 and TNP-50 were determined by their X-ray diffraction patterns. The hydrodynamic size and the Zeta potential of the naked TNPs and NP-protein complexes were determined according to the method in the previous study \[[@pone.0122591.ref021]\]. Briefly, dynamic diameter of TNPs was measured by a particle size analyzer (Malvern Nano ZS90, Malvern, UK). TNPs were suspended in water or culture medium with 10% fetal bovine serum. For Zeta potentials analysis, TNPs were first diluted either in ultrapure water (18.2 MΩ) or in 10% FBS. After 24 h incubation, free and loose bound proteins were removed by centrifugation (13 000 rpm), and TNPs were washed and centrifuged for three times. The protein bound TNPs were then dispersed in water for their zeta potential measurement in a Malvern Nano ZS90 Zetasizer. Each material was tested three times.

Mice and dosing {#sec004}
---------------

Timed pregnant CD-1 mice were purchased from Beijing Vital River Laboratories (Beijing, China).

The hour of the day at which a dam gave birth was designated as LD 0. The litter sizes were normalized to eight (four males and four females) on LD 2. At LD 2, the dams were randomly divided into eleven groups with seven per group (LD 10 endpoint group and LD 21 endpoint group). The dams targeted for LD 10 or LD 21 endpoint groups were dosed intravenously through the tail vein with PBS, TNP**-**8 (2, 6, and 8 mg/kg), and TNP**-**50 (2, 6, and 8 mg/kg) at LD 2, 4, 6, 8. Dams from a group for LD 10 end point were subcutaneously injected with CdCl~2~ (2 mg/kg) at LD 2, 4, 6, and 8.

Ethics Statement {#sec005}
----------------

Our experimental protocols complied with the NIH guidelines outlined in the *Guide for the Care and Use of Laboratory Animals* and were approved by a local ethics committee.

TNPs and TNPs injection solution preparation {#sec006}
--------------------------------------------

The two TNPs' purity which was given by the manufacturer was 99.81%. The TNP nanoparticles were dispersed in sterile PBS. Before injection, the solution was sonicated for 10 min, and vortexed for 1 min.

Animal samples {#sec007}
--------------

### Milk {#sec008}

Milk samples were obtained from dams at LD 10. Briefly, the entire litter was separated from the dam for approximately 2 h prior to milking. The dams were anesthetized with sodium pentobarbital (50 mg/kg) (Sigma, USA) by i.p. injection before milk collection. Then dams were given 2 IU of oxytocin (Sigma, USA) through i.p. injection. Milk collection from the right third thoracic mammary gland was initiated within 5 min after the administration of oxytocin. The ejected milk was collected by gentle aspiration\[[@pone.0122591.ref022]\]. The milk samples were frozen immediately and stored at -80°C.

### Blood and organs {#sec009}

The dams of LD 10 and LD 21 endpoint groups were sacrificed after anesthesia using sodium pentobarbital at LD 10 and LD 21. Blood was added to heparin tube, plasma was harvested by centrifugation at 600 g for 15 min. The heart, liver, spleen, lungs, kidneys, uterus, and ovaries were collected and weighed. Mammary gland tissues for biodistribution analysis, oxidative stress analysis, RNA and protein extraction were placed on dry ice and stored at -80°C. To minimize individual variations, the left fourth and fifth inguinal mammary glands from each mouse were used for histopathological examination. The right fourth and fifth inguinal mammary glands from each mouse were used for RNA isolation, protein extraction, and analysis of oxidative stress. Left kidney, lung, and the left first, second, and third thoracic mammary glands were used for biodistribution study.

### GI tract of Pups {#sec010}

After separation from the dams, the pups were weighed and sacrificed after anesthesia by cervical dislocation at LD 10. The GI tracts, including stomach and intestine from eight pups were excised and pooled for Ti content analysis. For LD 21 endpoint group, the pups were observed for hair growth beginning at LD 10 and for eye opening beginning at LD 13.

Measurement of oxidative stress {#sec011}
-------------------------------

The methods for homogenate preparation and analyses were carried out according to established procedures\[[@pone.0122591.ref023]\]. The livers and mammary gland tissues were homogenized in cold PBS using a tissue homogenizer (Bio-Gen PRO200 Homogenizer, Oxford, CT, USA) after weighing. The homogenates were centrifuged at 3,000 g for 15 min at 4°C and then the supernatant was collected. The malondialdehyde (MDA) and glutathione (GSH) levels in the supernatants were analyzed using MDA assay kit and GSH assay kit (Nanjing Jiancheng Bioengineering Institute, Jiangsu, China).

Histopathological examination and counting of shed cells {#sec012}
--------------------------------------------------------

Tissues from heart, liver, spleen, lungs, kidney and mammary gland were fixed in 10% formalin neutral buffer solution for 24 h. Paraffin-embedded sections (5 μm) of tissues were stained with hematoxylin and eosin. The pathologist was blinded to the identity and analysis of the pathology sections. To quantitatively analyze the numbers of cells shed into the alveolar lumen, seven mice per group were examined and approximately 100 images of alveoli per mouse were examined and counted.

Protein extraction and Western blot analysis {#sec013}
--------------------------------------------

Frozen mammary glands (0.1 g) were homogenized in 1.5 mL of whole-cell homogenization buffer (20 mM HEPES \[pH 7.9\]/ 20% (v/v) glycerol/ 250 mM KCl/ 2 mM MgCl~2~/ 0.2 mM EDTA/ 0.5 mM dithiothreitol/ 1 mM PMSF/ 0.1% Triton X-100/ 5 μL/mL of buffer). The extracts were centrifuged (50,000 g, 4°C, 15 min), and the supernatants were collected for subsequent analysis. The concentrations of the lysates were determined using a BCA assay (Bio-Rad, CA, USA). Equal volumes of protein (20 μg) were loaded onto 10% SDS/PAGE gels and then electrophoretically transferred onto a polyvinylidene difluoride membrane (Millipore, MA, USA) using a Mini Trans-Blot cell (Bio-Rad, CA, USA). The membranes were then incubated in 5% bovine serum albumin (BSA) (Sigma, USA) in Tris-buffered saline (TBS) with 0.1% Tween 20 and shaken for 1 h at room temperature, followed by incubation overnight at 4°C with primary antibodies against occludin (Epitomics, CA, USA), ZO-1 (Abcam, MA, USA) and GAPDH (ImmunoWay Biotechnology Company, Newark, DE, USA). The membranes were washed with TBS with 0.1% Tween 20 and probed with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Bio-Rad, CA, USA). The proteins were detected with the Luminata Forte Western HRP substrate (Millipore, MA, USA) according to the manufacturer's instructions.

Titanium Content Analysis {#sec014}
-------------------------

The methods for titanium analysis were carried out according to established procedures \[[@pone.0122591.ref024], [@pone.0122591.ref025]\]. Tissue samples of approximately 0.2 g were weighed, digested, and analyzed for titanium content. The samples were digested in a microwave oven after the addition of 3 mL of ultrapure nitric acid and 1 mL of hydrogen peroxide. The digested solutions were diluted with ultrapure water. The titanium content was analyzed using inductively coupled plasma-mass spectrometry (ICP-MS, Agilent 7700, Santa Clara CA, USA). Indium (20 ng/mL) was used as an internal standard. The detection limit of titanium was 1.87 ng/L.

Statistical Analysis {#sec015}
--------------------

All of the statistical calculations were performed using SigmaPlot 12.0. The results are reported as the mean±s.d. of multiple independent determinations. The comparisons between the control and experimental groups and the differences within experimental groups at different doses were analyzed using one-way ANOVA followed by least-significant difference or Tukey's tests. A P value of less than 0.05 was considered significant.

Results and Discussion {#sec016}
======================

Accumulation of TNPs in major organs does not induce acute toxicity in lactating dams {#sec017}
-------------------------------------------------------------------------------------

The physiochemical properties of nanoparticles are vital to their biological activities \[[@pone.0122591.ref026]--[@pone.0122591.ref028]\]. Particle size, zeta potential, agglomeration, and crystal structure of TNP-8 and TNP-50 were determined and summarized in [Fig 1](#pone.0122591.g001){ref-type="fig"}. Both larger and smaller TNPs had anatase structure as shown by their X-ray diffraction patterns ([Fig 1](#pone.0122591.g001){ref-type="fig"}). The TNPs also had similar zeta potential values in water and plasma, suggesting that their surface electrostatic and electrodynamic properties were very similar. In water, nanoparticles of both sizes exhibited a slight aggregation due to the tendency of nanoparticles to minimize their surface energy in aqueous suspension.

![Characterization of TNPs.](pone.0122591.g001){#pone.0122591.g001}

Although medicinal application of TNPs often involves a direct i.v. injection \[[@pone.0122591.ref006]\], environmental exposures through oral, dermal, or inhalation routes all lead to the absorption of nanoparticles into the circulation followed by the translocation of nanoparticles to various organs \[[@pone.0122591.ref017], [@pone.0122591.ref025], [@pone.0122591.ref029], [@pone.0122591.ref030]\]. During the lactation period, there is an increased blood flow to the mammary glands. This may facilitate the transfer of nanoparticles from blood to mammary glands \[[@pone.0122591.ref031]\]. Based on this, we chose i.v. administration for the toxic study of lactating mammary gland. To simulate these processes, we give mice four i.v. injections of TNPs at doses of 2, 6, and 8 mg/kg ([Fig 2A](#pone.0122591.g002){ref-type="fig"}).

![TNP exposure scheme and biodistribution of TNPs in lactating dams after intravenous injection.\
(A) TNP exposure scheme. Lactating dams received exposure of TNP**-**8 or TNP-50 at lactation day (LD) 2, 4, 6, and 8 at a dose of 2, 6 or 8 mg/kg body weight via intravenous administration. (B) Ti content in major organs of lactating dams at LD 10 after four doses of TNPs (8 mg/kg) at LD 2, 4, 6 and 8. Ti content in PBS group showed the basal Ti level in various organs. (C) Ti content in mammary glands at LD 10 after dams were exposed to four doses of TNPs at indicated doses at LD 2, 4, 6 and 8. The symbol \* represents significant difference from the PBS group (P\<0.05) and \# represents significant difference from the TNP-8 group (P\<0.05). In both B and C, data are mean±s.d. (n = 7 per group).](pone.0122591.g002){#pone.0122591.g002}

We first examined the organ accumulation of the TNPs using inductively coupled plasma mass spectrometry (ICP-MS) \[[@pone.0122591.ref025], [@pone.0122591.ref032]\]. TNPs were accumulated more readily in reticuloendothelial (RES) organs, liver and spleen at lactation day 10 (LD 10) as found in other studies \[[@pone.0122591.ref017], [@pone.0122591.ref033]\]. In comparison, the accumulation in the lungs, heart, and kidneys were much less ([Fig 2B](#pone.0122591.g002){ref-type="fig"}). This showed that TNP**-**8 and TNP-50 were primarily cleared from blood by RES system organs. The relatively low accumulation of TNPs in the kidney suggested that urinary excretion is not the main excretion pathway for TNPs.

TNPs of both sizes were found accumulated in mammary glands ([Fig 2C](#pone.0122591.g002){ref-type="fig"}). Titanium accumulation in mammary gland was more evident for higher exposure groups and for smaller nanoparticles showing that nanoparticles accumulation in mammary gland of lactating mice was size- and dose-dependent ([Fig 2C](#pone.0122591.g002){ref-type="fig"}). The internal exposure doses of TNP-8 and -50 in mammary glands at an applied dose of 8 mg/kg were approximately 82 and 35 ng Ti/g tissue, respectively, at LD 10. In comparison, the internal doses of TNP-8 and -50 in liver were 2,299.6 and 2,369.2 ng Ti/g.

The next question was whether the four i.v. injections of TNPs at 8 mg/kg could induce acute systemic toxicity in dams. During the entire lactation period, none of the dams exhibited abnormal behaviors in routine activities. There were no significant changes in body weight ([S1A Fig](#pone.0122591.s001){ref-type="supplementary-material"}), relative organ weights ([S1B](#pone.0122591.s001){ref-type="supplementary-material"} and [S1C](#pone.0122591.s001){ref-type="supplementary-material"} Fig), or food consumption ([S1D Fig](#pone.0122591.s001){ref-type="supplementary-material"}) compared with the control mice. Pathological examinations of major organs found no TNP-induced tissue injury after exposure at the highest dose ([S2 Fig](#pone.0122591.s002){ref-type="supplementary-material"}).We also analyzed possible TNP-induced physiological alterations as reflected in blood. At LD 10, there was no abnormal alteration in hematology indicators ([S1 Table](#pone.0122591.s005){ref-type="supplementary-material"}). The above results indicated that, at 8 mg/kg, the systemic toxicity of these two TNPs to dams was minimal during the lactation period.

Several *in vivo* toxicity studies were reported previously at considerably higher doses and via other administration routes. Intragastric administration of TNPs with a diameter of 5 nm at a dose of 125 or 250 mg/kg to mice induced relative organ weight increases for the liver, kidney, and spleen as well as alterations in hematological characteristics \[[@pone.0122591.ref034]\]. The intraperitoneal (i.p.) administration of TNPs with a diameter of 100 nm at doses of 1,940 and 2,590 mg/kg to mice caused acute toxicity, as indicated by passive behavior, loss of appetite, tremor and death \[[@pone.0122591.ref032]\]. The much lower doses used in our study compared to previous studies might account for the lack of systemic toxicity. However, considering the vulnerability of mammary glands and their crucial function in feeding the newborns, it was highly desirable to examine the effects of TNPs on this organ and on pups at a dose that caused no systemic toxicity to dams.

In this study, TNPs caused cell shedding and tight junction disruption in a size-dependent manner. The exposure dose was expressed as particle mass concentration. In nanotoxicity/ nanomedicine studies, dose can also be expressed as particle surface area or particle number \[[@pone.0122591.ref035], [@pone.0122591.ref036]\]. Previous study shows that toxicity is dependent on dosage. Smaller nanoparticle often shows a greater toxicity when using mass concentration in agreement with our findings.

TNP-induced oxidative stress in mammary glands impairs tight junction of blood-milk barrier {#sec018}
-------------------------------------------------------------------------------------------

The generation of oxidative stress by nanomaterials is suggested to be one of the main reasons for nanoparticle-induced tissue damages in testis \[[@pone.0122591.ref019]\], brain \[[@pone.0122591.ref027], [@pone.0122591.ref037]\], liver \[[@pone.0122591.ref038], [@pone.0122591.ref039]\], placenta and fetuses \[[@pone.0122591.ref018], [@pone.0122591.ref040]\]. Moreover, neutrophil-induced oxidative stress was found to damage mammary gland tissues in animals with mastitis (inflammation of the breast) \[[@pone.0122591.ref041], [@pone.0122591.ref042]\]. The accumulation of TNPs in lactating mammary glands suggested that TNPs might generate local oxidative stress. To evaluate the oxidative stress level in mammary glands, we analyzed the concentrations of two oxidative stress markers, malondialdehyde (MDA) and glutathione (GSH), in mammary glands. The exposure of the dams to TNP-8 and TNP-50 at 8 mg/kg increased the MDA level and decreased the GSH level in mammary glands (Fig [3A](#pone.0122591.g003){ref-type="fig"} and [3B](#pone.0122591.g003){ref-type="fig"}). The mammary glands exhibited a considerably lower antioxidative capability than the liver, as indicated by a comparison of the net increases in MDA and decreases in GSH in mammary glands and liver when the internal doses of TNPs were normalized to the same value ([Fig 3C](#pone.0122591.g003){ref-type="fig"}). As shown in [Fig 3C](#pone.0122591.g003){ref-type="fig"}, the TNP-induced oxidative stress in mammary glands would be 15--130 times higher than that in the liver if the internal dose were normalized to the same level. This indicated that mammary glands were more vulnerable to nanoparticle-induced oxidative stress. The lower antioxidative capability of mammary glands, combined with the TNP-induced oxidative stress suggested the possibility of tissue injury in the mammary glands of lactating dams.

![Determination of levels of MDA (A), GSH (B), Linear correlation between dose and MDA in mammary gland (C) and comparison of TNP generated oxidative stress in mammary glands and liver (D) at LD 10 after four doses of TNP exposures (8 mg/kg) at LDs 2, 4, 6 and 8.\
Seven mice in each group were examined. Data are mean±s.d. (n = 7 per group). Values in \"\" are hypothetical values when the internal dose in mammary gland were 1000 μg Ti/g tissue. The symbol \* represents significant difference from the PBS group (P\<0.05). ΔMDA = (Liver MDA in TNP groups)--(Liver MDA in PBS groups). $MDA~per~1000~\mu g~ = ~\frac{\Delta~MDA}{internal~dose} \times 1000$. ΔGSH and GSH per 1000 μg were obtained similarly.](pone.0122591.g003){#pone.0122591.g003}

Mammary alveolar epithelial cells are polarized secretory cells ([Fig 4A](#pone.0122591.g004){ref-type="fig"}). These cells synthesize milk proteins and secrete milk. There are tight junctions between the basal (blood) and apical (milk) sides of alveolar epithelial cells. The vital function of this barrier is to prohibit the direct paracellular exchange of substances between vascular and milk compartments during the lactation period. Because peak lactation in rodents occurs on LD 10, we first preformed histological examination of the integrity of mammary glands at LD 10 ([Fig 4B](#pone.0122591.g004){ref-type="fig"}--[4D](#pone.0122591.g004){ref-type="fig"}). The mammary glands of the lactating dams after PBS treatment contained intact alveolar epithelial cells. There was no noticeable cell shedding into the alveolar lumen ([Fig 4Bi](#pone.0122591.g004){ref-type="fig"}). After treatment with TNP**-**8 or TNP-50 at 2 mg/kg, the mammary glands showed no pathological alterations compared to the PBS group ([Fig 4Bii](#pone.0122591.g004){ref-type="fig"} for TNP**-**8 and [Fig 4Ci](#pone.0122591.g004){ref-type="fig"} for TNP**-**50). As the exposure dose increased, more shedding of epithelial cells into the alveolar lumen was observed ([Fig 4Biii](#pone.0122591.g004){ref-type="fig"} for TNP**-**8 and [Fig 4Cii](#pone.0122591.g004){ref-type="fig"} for TNP**-**50). Cell shedding became more severe when dams were exposed to a higher dose of TNP ([Fig 4Biv and v](#pone.0122591.g004){ref-type="fig"} for TNP**-**8 and [Fig 4Ciii and iv](#pone.0122591.g004){ref-type="fig"} for TNP**-**50). At the highest dose used (8 mg/kg), hyperplasia and stress-induced adipocytes were observed only for TNP**-**8 treatment ([S3A](#pone.0122591.s003){ref-type="supplementary-material"} and [S3B](#pone.0122591.s003){ref-type="supplementary-material"} Fig). The loss of mammary gland epithelial cells may produce defects or gaps in the tight junction of blood-milk barrier. By examining seven mice per exposure group and approximately 100 histological images for each mouse, we quantitatively determined the number of shed cells after each exposure. Our data showed that the smaller TNPs caused more cell shedding than the larger TNPs and cell shedding induced by both TNPs was dose-dependent ([Fig 4D](#pone.0122591.g004){ref-type="fig"}).

![Shedding of mammary alveolar epithelial cells induced by TNPs.\
A. Schematic anatomical diagrams of lactating mammary glands during lactation period and cartoon indicates that ROS induced cell shedding. B. Representative histological micrographs of the mammary glands 10 days after treatment with (i) PBS; (ii) TNP**-**8 at a dose of 2 mg/kg; (iii) TNP**-**8 at a dose of 6 mg/kg; (iv) TNP**-**8 at a dose of 8 mg/kg. Cell shedding and barrier loosening are noted; (v) Severe cell shedding into alveolar lumen is evident at a dose of 8 mg/kg; (vi) An enlarged view of cell shedding. C. Representative histological micrographs of the mammary glands 10 days after treatment with (i) TNP**-**50 at a dose of 2 mg/kg; (ii) TNP**-**50 at a dose of 6 mg/kg; (iii) TNP**-**50 at a dose of 8 mg/kg; (iv) Cell shedding into alveolar lumen is observed at a dose of 8 mg/kg. D. Quantification of numbers of mammary alveolar epithelial cells shed into the alveolar lumen. There were 7 mice in each experimental group and around 100 alveoli images were examined for each mouse. Scale bar: 40 μm; Narrow arrows indicate gap; Thick arrows indicate cell shedding.](pone.0122591.g004){#pone.0122591.g004}

The mammary alveolar epithelial cells and tight junctions between these cells form an important part of blood-milk barrier \[[@pone.0122591.ref043], [@pone.0122591.ref044]\]. This tight junction is impermeable during the lactation period to prohibit the direct paracellular exchange of substances between the vascular and milk compartments \[[@pone.0122591.ref043]\]. Tight junction for biological barrier is, however, susceptible to disruption by stimuli such as oxidative stress \[[@pone.0122591.ref045]\], microbes, or endotoxins \[[@pone.0122591.ref046]\]. For example, fine particles have been shown to induce ROS and alter the tight junction integrity with associated loss of tight junction proteins such as ZO-1 \[[@pone.0122591.ref047]\] or both occludin and ZO-1\[[@pone.0122591.ref048]\].

Previous studies have shown that transcytosis of nanoparticles through endothelial cell layers is a rare event \[[@pone.0122591.ref049], [@pone.0122591.ref050]\]. The tight junction proteins ZO-1 and occludin are two key proteins that maintain the integrity of epithelial cell tight junctions in mammary glands \[[@pone.0122591.ref051]\]. Because TNPs induced local oxidative stress in mammary glands, we hypothesized that this might compromise the tight junctions of the blood-milk barrier by down-regulating the expression of integral proteins occludin and ZO-1 ([Fig 5A](#pone.0122591.g005){ref-type="fig"}). To test this hypothesis, we quantitatively analyzed the expression of occludin and ZO-1 in mammary gland tissues using Western blot and band intensity analysis with ImageJ software (Wayne Rasband, NIH, Bethesda, Maryland, USA). We observed a dose-dependent decrease of both proteins (Fig [5B](#pone.0122591.g005){ref-type="fig"} and [5C](#pone.0122591.g005){ref-type="fig"}). These results indicated that exposure of the dams to TNPs caused a reduced expression of key tight junction proteins ZO-1 and occludin and the shedding of epithelial cells in the mammary glands. We speculate that TNP-induced oxidative stress in mammary glands may be associated with cell shedding and the loss of tight junction proteins. However, whether there is casual link between cell shedding and tight junction disruption awaits further investigations. These perturbations significantly compromised the integrity of the blood-milk barrier. As a result, a possibility may exist that TNPs may leak into milk and reach the GI tracts of pups during milk feeding.

![Effects of TNPs on mammary gland tight junction proteins ZO-1 and occludin after four doses of TNPs exposure (2, 6, 8 mg/kg) to dams at LDs 2, 4, 6 and 8.\
(A) A plausible mechanistic schematic showing TNPs made cell shedding and loose the tight junction between the mammary gland epithelial cells through oxidative stress. (B) Western blot of ZO-1 and occludin in mammary glands. (C) Bar graphs show relative levels of tight junction proteins ZO-1 and occludin by normalizing PBS group to 1.0. The symbol \* represents significant difference from the PBS group (P\<0.05), (n = 3).](pone.0122591.g005){#pone.0122591.g005}

Damaged blood-milk barrier allowed TNPs to enter pup's GI tracts possibly through milk feeding {#sec019}
----------------------------------------------------------------------------------------------

Milk production and secretion are key functions of mammary glands. The disruption of tight junctions in mammary glands caused the transfer of small molecules from blood and interstitial spaces to milk \[[@pone.0122591.ref052]\]. It is intuitive that damage to the blood-milk barrier may also cause the transfer of TNPs from blood to milk. To demonstrate this transfer, it would be highly desirable to show the existence of TNPs in maternal milk. Technically, this experiment is very challenging because the tiny amount of secreted milk from a mouse is difficult to collect for ICP-MS analysis. Because milk is the only food source for newborn pups, TNPs may enter the pup's GI tract through the milk feeding. To test this possibility, we analyzed the Ti content in pups' GI tracts at LD 10 using ICP-MS (five dams per group, combined tissues from eight pups per dam). Our results demonstrated that Ti was accumulated in the GI tracts of the pups at LD 10 when TNP-8 particles were administered to the dams at a dose of 8 mg/kg ([Fig 6A](#pone.0122591.g006){ref-type="fig"}). In contrast, accumulation of Ti was not evident for larger TNP**-**50 or lower doses of TNP**-**8 particles. By analyzing Ti content in pups, we found that Ti content in GI tracts of pups is generally higher with a small standard deviation. Since the main activity of pups in lactation period was milk sucking, the probability of Ti transmission through random contamination from dam's feces and urine was very low. The observed TNP**-**8 transfer from dams to pups during milk feeding at a maternal exposure dose of 8 mg/kg was consistent with the observed higher oxidative stress induction ([Fig 3C](#pone.0122591.g003){ref-type="fig"}) and tight junction damage (Figs [4B](#pone.0122591.g004){ref-type="fig"} and [5B](#pone.0122591.g005){ref-type="fig"}) by TNP**-**8 at this dose ([Fig 6B](#pone.0122591.g006){ref-type="fig"}). Nanoparticles have also been found to damage other biological barriers, such as the placental barrier \[[@pone.0122591.ref018], [@pone.0122591.ref053]\] and blood-testis barrier \[[@pone.0122591.ref020]\].

![The Ti content in pups' GI tract and a cartoon presentation showing that TNPs cross the damaged tight junction entering the milk in lactating dams.\
(A) Ti content in pups' GI tract at LD 10 after four doses of TNP exposures to lactating dams at LD 2, 4, 6 and 8. Symbol \* represents significant difference from the PBS group (P\<0.05). GI tract tissues from eight pups were collected per dam and pooled. There are five dams in each group. Data are mean±s.d. (B) A cartoon presentation showing that TNPs cross the damaged tight junction entering the milk in lactating dams.](pone.0122591.g006){#pone.0122591.g006}

Milk nutrient and pup development not compromised during lactation period {#sec020}
-------------------------------------------------------------------------

Dam's milk is the only food source for pups during lactation period. Nutrient proteins in the milk play at least three crucial roles: providing nutrition, defending pups against infection, and facilitating the development of physiological functions \[[@pone.0122591.ref054]\]. For example, β-casein plays critical roles in calcium solubility and absorption. The expression of the β-casein gene has been considered an indicator of milk protein synthesis \[[@pone.0122591.ref055]\]. α-Lactalbumin is a common whey protein that plays multiple protective functions in the newborns \[[@pone.0122591.ref056]\]. Lactoferrin is an antimicrobial component \[[@pone.0122591.ref057], [@pone.0122591.ref058]\]. Epithelial growth factor (EGF) functions in stimulating the growth of the gut and various epidermal/epithelial tissues as well as preventing bacterial infection \[[@pone.0122591.ref059]\].

The detection of TNPs in pup's GI tract suggested that TNPs might enter milk and affect milk components and nutrition. Therefore, we next investigated the impact of TNPs on nutrient quality of milk by harvesting milk from the mammary gland tissue of lactating dams at LD 10 and analyzing key nutrient proteins in the milk.

Although, the positive control, CdCl~2~ (2 mg/kg), downregulated the transcription of the genes encoding β-casein, α-lactalbumin, lactoferrin, and EGF from quantitative PCR analysis ([Fig 7A](#pone.0122591.g007){ref-type="fig"}) as well as the expression of lactoferrin protein (Fig [7B](#pone.0122591.g007){ref-type="fig"} and [7C](#pone.0122591.g007){ref-type="fig"}), TNPs did not reduce the expression of key milk components at both mRNA and protein levels ([Fig 7A](#pone.0122591.g007){ref-type="fig"}--[7C](#pone.0122591.g007){ref-type="fig"}) when dams were exposed to TNPs at a dose of 8 mg/kg. These data indicated that the leakage of TNPs into milk did not deteriorate the nutrient quality of the milk. Milk supplies all of the nutrients required for neonatal growth \[[@pone.0122591.ref012]\], cognitive and psychosocial development \[[@pone.0122591.ref014]\], and immune defense \[[@pone.0122591.ref013]\]. Approximately 80--95% of the proteins in milk are synthesized in mammary alveolar epithelial cells \[[@pone.0122591.ref060]\]. The absence of a short-term negative effect of TNPs on the nutrient quality of milk was observed in this study. This result indicated that the TNPs had minimal effects on the synthesis of milk proteins even though they disrupted the blood-milk barrier.

![Analysis of nutrient quality of milk in the lactating dams (A, B and C) and effects of TNP exposures to dams on developmental landmarks of pups during lactation period (D, E).\
(A) The mRNA levels of β-casein, lactoferrin, α-lactalbumin and epidermal growth factor in mammary gland tissue were analyzed at LD 10 by quantitative PCR assay after dosing of TNPs at 8 mg/kg to dams. Data are mean±sd. (n = 4) (B) Western blot of key milk proteins. (C) Bar graphs show relative levels of β-casein, lactoferrin, α-lactalbumin and epidermal growth factor by normalizing PBS group to 1.0. (D) Body weight gains of pups during the lactating period when dams were dosed with PBS, TNP-8 or TNP-50 (8 mg/kg BW) at LDs 2, 4, 6 and 8. (n = 7) (E) Effects of TNP treatments on key developmental landmarks of pups during lactation period. The symbol \* represents significant difference from the PBS group (P\<0.05).](pone.0122591.g007){#pone.0122591.g007}

However, the development of pups during the lactation period might still be a concern for at least three reasons: (1) possible alterations in other protein components in milk; (2) the quantity of secreted milk might be reduced by TNPs; and (3) the TNP leakage to the GI tracts of pups might cause damages to pup's systems. Therefore, we next examined the developmental landmarks of pups during the lactation period.

To accomplish this, we recorded pups' body weight gains ([Fig 7D](#pone.0122591.g007){ref-type="fig"}), viability at weaning (LD 21), and other major physical developmental landmarks ([Fig 7E](#pone.0122591.g007){ref-type="fig"}). All the pups gained weight at the same rate as the pups in the control group. The average days for eye opening and hair growth for pups from the TNP-treated dams were nearly identical to those of the control pups. All groups also had identical weaning day viability (100%).

Regarding the effects of TNP accumulation in the mammary glands of dams on their ability to secrete milk, we did not have a quantitative method for measuring milk secretion. However, based on the comparable body weight gains in the pups from the TNP-treated and control dams, we inferred that the quantity of secreted milk was not likely reduced by TNP accumulation in the mammary glands of dams during the lactation period.

Despite the lack of effects to pups during lactation period, the long term effects of these exposures cannot be ignored. Carbon nanoparticles administered to pregnant mice have been reported to cause defects in the reproductive systems of male offspring \[[@pone.0122591.ref061]\]. It was also reported that a decline of spatial recognition memory and learning of offspring caused by exposure of TiO~2~ nanoparticles to dams during lactation period \[[@pone.0122591.ref062]\]. This is probably due to the fact that hippocampal development and neurobehavioral development occur during lactation period rather than prenatal period \[[@pone.0122591.ref016]\].

Conclusion {#sec021}
==========

In summary, we use lactating mice as a model in this investigation to examine the size- and dose-dependent effects of TNPs on lactating dams and pups. After i.v. administration, TNPs accumulated in the mammary glands, in addition to other organs, in a size-dependent manner. Nanoparticles generate oxidative stress in mammary glands and cause damages to the tight junction in blood-milk barrier as indicated by the shedding of epithelial cells. TNP-induced mammary gland damage and the leakage of nanoparticles to pups through milk feeding are highly dependent on the size of the nanoparticles. The accumulation of TNPs in the GI tracts of pups was observed only for smaller TNP-8 particles after milk feeding. Although the primary sizes of TNPs are discussed, we emphasize here that nanoparticles exist mainly as aggregates and they are actually more biologically relevant. Under our exposure scheme and doses, the nutrient proteins in milk were not compromised and the developmental landmarks of the pups were not affected through the weaning day. However, the effects of higher doses and effects of other nanoparticles still need to be elucidated and the long-term effects of such exposures on offsprings remain to be clarified.

Supporting Information {#sec022}
======================

###### Effects of TNP exposure on dams during lactation.

\(A\) Change in body weight of dams during and after exposures to four doses of TNPs (8 mg/kg) at LD 2, 4, 6, and 8. Relative organ weights of dams at LD 10 (B) and 21 (C) after exposures to four doses of TNPs (8 mg/kg) at LD 2, 4, 6 and 8. (D) Food consumption by dams during whole lactation period (21 days) after exposures to four doses of TNPs (8 mg/kg) at LD 2, 4, 6 and 8. Seven mice in each group were examined. Data are mean±s.d. (n = 7 per group).

(TIF)

###### 

Click here for additional data file.

###### Histopathological micrographs of major organs in dams at LD 10 after exposures to four doses of TNP (8 mg/kg).

Seven dams in each group were used for histological examination.

(TIF)

###### 

Click here for additional data file.

###### Pathology of mammary glands of TNP-8 at a dose of 8 mg/kg.

Red triangles and arrows indicate stress-induced adipocytes and hyperplasia respectively.

(TIF)

###### 

Click here for additional data file.

###### Additional materials and methods.

(DOCX)

###### 

Click here for additional data file.

###### Blood biochemistry (A) and hematology (B) of dams after TNP-8 and -50 exposure (8 mg/kg) at LD 10.

(DOCX)

###### 

Click here for additional data file.
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